S-1 EX-FILING FEES 0001652935 N/A N/A 0001652935 1 2026-07-31 2026-07-31 0001652935 2 2026-07-31 2026-07-31 0001652935 3 2026-07-31 2026-07-31 0001652935 2026-07-31 2026-07-31 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Actuate Therapeutics, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common stock   (1)   457(o)       $     $ 34,500,000.00   0.000087   $ 3,001.50
Fees to be Paid   Equity   Warrants to be issued to the underwriter   (2)   Other               0.00   0.000087     0.00
Fees to be Paid   Equity   Common stock underlying warrants to be issued to the underwriter       457(o)       $     $ 1,509,375.00   0.000087   $ 131.32
                                           
Total Offering Amounts:   $ 36,009,375.00         3,132.82
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 3,132.82

__________________________________________
Offering Note(s)

(1) In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transactions.

The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act.
(2) No registration fee required pursuant to Rule 457(g).

We have agreed to issue to the underwriter warrants to purchase shares of common stock representing up to 3.5% of the common stock issued in the offering. The underwriter’s warrants are exercisable at a per share exercise price equal to 125% of the public offering price per share of the common stock offered hereby.